{LONGTERMINVESTORS} Alkem Laboratories was down 3.67% after the company said that U S Food and Drug Administration (USFDA) had conducted an inspection at the company's API (active pharmaceutical ingredient) manufacturing facility located at Ankleshwar, India from 5 December 2016 to 9 December 2016. In this regard, the company has received the inspection report which contains three 483 observations. The company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations and the same is proposed to be filed within the timeline stipulated by USFDA. The announcement was made during trading hours today, 12 December 2016.

Alkem Laboratories was down 3.67% after the company said that U S Food and Drug Administration (USFDA) had conducted an inspection at the company's API (active pharmaceutical ingredient) manufacturing facility located at Ankleshwar, India from 5 December 2016 to 9 December 2016. In this regard, the company has received the inspection report which contains three 483 observations. The company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations and the same is proposed to be filed within the timeline stipulated by USFDA. The announcement was made during trading hours today, 12 December 2016.

--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.